These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1623657)

  • 21. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
    Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L
    Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
    Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambulatory blood pressure profiles in patients treated with once-daily diltiazem extended-release or indapamide alone or in combination.
    Prisant LM;
    Am J Ther; 2000 May; 7(3):177-84. PubMed ID: 11317166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension.
    Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D
    Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
    Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
    Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of diltiazem administered once and twice daily.
    Mooser V; Waeber B; Nussberger J; Brunner HR
    J Hum Hypertens; 1988 Dec; 2(4):257-60. PubMed ID: 3236328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
    Nikkilä M; Inkovaara J; Heikkinen J
    Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
    Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
    J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
    Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
    Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.
    Dahlöf C; Hedner T; Thulin T; Gustafsson S; Olsson SO
    Eur J Clin Pharmacol; 1991; 40(5):453-60. PubMed ID: 1884720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
    Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.